<DOC>
	<DOCNO>NCT02730533</DOCNO>
	<brief_summary>This single-centre , randomised , endoscopist-blind , parallel-group study patient schedule endoscopic submucosal dissection ( ESD ) gastric mucosal lesion . The primary objective observe whether regimen 7-day oral esomeprazole premedication alleviate intraoperative bleeding patient schedule ESD due gastric mucosal lesion .</brief_summary>
	<brief_title>The Efficacy Esomeprazole Premedication Intraoperative Bleeding During Gastric ESD</brief_title>
	<detailed_description />
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Stomach Neoplasms</mesh_term>
	<mesh_term>Blood Loss , Surgical</mesh_term>
	<mesh_term>Proton Pump Inhibitors</mesh_term>
	<mesh_term>Esomeprazole</mesh_term>
	<criteria>Ability understand willingness sign write informed consent document . Female male age ≥18 year . Patients must gastric mucosal lesion eligible ESD indication ( Japanese Gastric Cancer Association 2011 ) , include early gastric cancer , polyp , adenoma , precancerous/suspected lesion diagnose endoscopy . Malignancy advance disease life expectancy &lt; 6 month judge investigator . The ASA classification physical status ≥ 4 judged investigator . Severe hepatic disease renal disease Ability understand willingness sign write informed consent document . Major cardiovascular event enrollment within 3 month prior enrollment stroke , myocardial infarction , hospitalization treatment unstable angina pectoris judge investigator . Haemorrhagic disorder . Patients history gastrectomy recurrent lesion . Known suspected hypersensitivity component PPI . Planned treatment : warfarin ( include vitamin K antagonist ) , cisapride , phenytoin , atazanavir , nelfinavir , digoxin , methotrexate , clopidogrel , tacrolimus , theophylline , lidocaine , nifedipine . Pregnancy , plan pregnancy lactation . Women childbearing potential must use reliable medically accept method birth control , judge investigator . Known suspect alcohol , drug medication abuse . Any condition associate poor compliance judge investigator . Participation study involve administration investigational product device within precede 14 day prior enrollment . Involvement plan conduct study . Previous enrollment present study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>endoscopic submucosal dissection</keyword>
	<keyword>proton pump inhibitor</keyword>
	<keyword>bleeding</keyword>
</DOC>